ArticleAmerican journal of translational research2025
Comparative evaluation of PECS II versus RISS block for postoperative analgesia in breast cancer surgery: a randomized controlled trial.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to investigate the analgesic effects of Pectoral Nerve Block Type II (PECS II) versus Rhomboid Intercostal and Subserratus Plane Block (RISS) after modified radical mastectomy (MRM) for breast cancer.
methodsThis prospective, double-blind, randomized controlled trial recruited 67 female patients undergoing unilateral MRM from December 1, 2023, to December 1, 2024 at Inner Mongolia Baogang Hospital. Patients were randomly assigned (1:1) to the PECS II group (n=30) or the RISS group (n=30). Primary outcomes included Quality of Recovery (QoR-40) scores at 6 and 24 hours and Visual Analogue Scale (VAS) pain scores in the PACU and at 2, 6, 12, 24, and 48 hours postoperatively. Secondary outcomes included sufentanil consumption via PCIA, the number of effective compressions, remifentanil use during surgery, additional analgesic administrations, sleep quality, and adverse events.
resultsThe PECS II group demonstrated significantly lower VAS scores than the RISS group at rest and during movement in the PACU and at 2, 6, 12, and 24 hours (P<0.05). The QoR-40 score at 6 hours was significantly higher in the PECS II group (P<0.0001). The remifentanil consumption, sufentanil dosage and effective compressions via PCIA during surgery were also significantly lower in the PECS II group, compared to the RISS group (P<0.0001).
conclusionPECS II block appears to be a more effective analgesic technique than RISS block for patients undergoing breast cancer surgery, providing better pain control, reducing opioid consumption, and potentially facilitating faster recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.